Pendal Group Ltd Takes Position in Masimo Co. (NASDAQ:MASI)

Share on StockTwits

Pendal Group Ltd bought a new stake in Masimo Co. (NASDAQ:MASI) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,997 shares of the medical equipment provider’s stock, valued at approximately $297,000.

Several other large investors have also recently modified their holdings of the company. FMR LLC boosted its holdings in shares of Masimo by 7.4% in the first quarter. FMR LLC now owns 4,178,808 shares of the medical equipment provider’s stock valued at $577,845,000 after acquiring an additional 289,246 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Masimo by 17.2% during the second quarter. Janus Henderson Group PLC now owns 691,953 shares of the medical equipment provider’s stock worth $102,976,000 after buying an additional 101,354 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Masimo by 14.6% during the fourth quarter. Geode Capital Management LLC now owns 547,027 shares of the medical equipment provider’s stock worth $58,734,000 after buying an additional 69,627 shares in the last quarter. Fundsmith LLP boosted its holdings in Masimo by 2.4% during the first quarter. Fundsmith LLP now owns 490,663 shares of the medical equipment provider’s stock worth $67,849,000 after buying an additional 11,291 shares in the last quarter. Finally, Ownership Capital B.V. boosted its holdings in Masimo by 7.0% during the first quarter. Ownership Capital B.V. now owns 445,026 shares of the medical equipment provider’s stock worth $61,538,000 after buying an additional 29,082 shares in the last quarter. 81.92% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ MASI opened at $151.25 on Friday. Masimo Co. has a 12-month low of $98.23 and a 12-month high of $160.25. The company has a market capitalization of $7.86 billion, a PE ratio of 49.92, a price-to-earnings-growth ratio of 2.29 and a beta of 1.14. The firm’s 50-day moving average is $152.70 and its two-hundred day moving average is $139.01.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, July 31st. The medical equipment provider reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.03. Masimo had a net margin of 22.15% and a return on equity of 17.82%. The company had revenue of $229.60 million for the quarter, compared to the consensus estimate of $222.46 million. During the same quarter in the prior year, the firm earned $0.73 earnings per share. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. As a group, equities research analysts expect that Masimo Co. will post 3.15 earnings per share for the current fiscal year.

A number of research firms recently commented on MASI. BidaskClub downgraded shares of Masimo from a “strong-buy” rating to a “buy” rating in a report on Tuesday, August 6th. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $153.00 price objective on the stock in a report on Wednesday, May 8th. Stifel Nicolaus boosted their price objective on shares of Masimo from $165.00 to $170.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. UBS Group boosted their price objective on shares of Masimo from $172.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Finally, BTIG Research reissued a “hold” rating on shares of Masimo in a report on Thursday, August 1st. One analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Masimo presently has an average rating of “Buy” and a consensus price target of $159.25.

In other news, COO Bilal Muhsin sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $140.00, for a total value of $1,400,000.00. Following the completion of the transaction, the chief operating officer now owns 10,000 shares of the company’s stock, valued at $1,400,000. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Anand Sampath sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, June 14th. The shares were sold at an average price of $142.39, for a total transaction of $4,271,700.00. Following the completion of the transaction, the executive vice president now directly owns 27,518 shares of the company’s stock, valued at approximately $3,918,288.02. The disclosure for this sale can be found here. Insiders sold 250,660 shares of company stock worth $37,641,208 in the last ninety days. Insiders own 11.50% of the company’s stock.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Story: Marijuana Stocks

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Advanced Micro Devices, Inc.  Shares Sold by Monetta Financial Services Inc.
Advanced Micro Devices, Inc. Shares Sold by Monetta Financial Services Inc.
Northeast Financial Consultants Inc Acquires 42,746 Shares of Vanguard Dividend Appreciation ETF
Northeast Financial Consultants Inc Acquires 42,746 Shares of Vanguard Dividend Appreciation ETF
Brokerages Set SLS International Inc  PT at $8.75
Brokerages Set SLS International Inc PT at $8.75
Monetta Financial Services Inc. Makes New Investment in Lululemon Athletica inc.
Monetta Financial Services Inc. Makes New Investment in Lululemon Athletica inc.
Monetta Financial Services Inc. Acquires New Position in AmerisourceBergen Corp.
Monetta Financial Services Inc. Acquires New Position in AmerisourceBergen Corp.
AXA Equitable Holdings Inc  Receives Consensus Recommendation of “Hold” from Analysts
AXA Equitable Holdings Inc Receives Consensus Recommendation of “Hold” from Analysts


© 2006-2019 Ticker Report